{
    "eid": "2-s2.0-85062191217",
    "title": "Pharmacokinetics and 48-week safety and efficacy of generic ritonavir tablet-boosted atazanavir in HIV-1-infected Thai adults",
    "cover-date": "2018-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Akarin Hiransuthikul",
        "Narukjaporn Thammajaruk",
        "Isariya Techatanawat",
        "Busarat Karachot",
        "Bancha Chuasuwan",
        "Chutima Manamuti",
        "Mariam Duereh",
        "Mathus Sawpitiporn",
        "Jiratchaya Sophonphan",
        "Sivaporn Gatechompol",
        "Anchalee Avihingsanon",
        "Chureeratana Bowonwattanuwong",
        "Kiat Ruxrungtham"
    ],
    "citedby-count": 2,
    "ref-count": 12,
    "ref-list": [
        "Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand",
        "Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE study",
        "A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adults",
        "Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): A randomised, open-label, non-inferiority trial",
        "Low-dose, once-daily atazanavir/ritonavir (200/100): An effective treatment for HIV-infected patients in Thailand",
        "Pharmacokinetics of atazanavir/ritonavir among HIV-infected Thai children concomitantly taking tenofovir disoproxil fumarate",
        "Atazanavir Ctroughis associated with efficacy and safety: Definition of therapeutic range",
        "Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients",
        "Heat-stable ritonavir tablets: A new formulation of a pharmacokinetic enhancer for HIV",
        "Atazanavir plasma concentrations vary significantly between patients and correlate with increased serum bilirubin concentrations",
        "Generic antiretroviral drugs and HIV care: An economic review"
    ],
    "affiliation": [
        {
            "affiliation-city": null,
            "@id": "60029201",
            "affilname": "Chonburi Regional Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029201",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60016965",
            "affilname": "The HIV Netherlands Australia Thailand Research Collaboration",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60015572",
            "affilname": "Thailand Government Pharmaceutical Organization",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015572",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Government Pharmaceutical Organization",
        "Government Pharmaceutical Organization of Thailand",
        "NHSO",
        "Thai National Health Security Office"
    ]
}